Scholars Central

Conference abstractPublished 17 Oct 2016

Chemical basis of treating chemotherapy-induced neutropenia in pediatric ALL patients by chamomile oral drop

Authors: Babak Daneshfard

Shiraz University of Medical Sciences, Iran

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Neutropenia is a blood disorder defined by a decrease in the absolute neutrophilic count (ANC) below the normal range. As a common complication of chemotherapy, it is associated with susceptibility to serious bacterial and fungal infections which could be life threatening. Matricaria chamomilla (Asteraceae), also called Baboone Shirazi in Traditional Persian Medicine (TPM) literature, is a globally used medicinal herb with a wide range of applications. Apigenin as one of the main components of chamomile is an anti-inflammatory agent which suppresses prostaglandin E2. Moreover, it plays an anxiolytic role by reducing GABA-activated chloride currents. Apigenin has also shown anti-cancer effects in human cell lines making chamomile a safe affordable anti-cancer agent. Results of a pilot controlled clinical trials on pediatric ALL patients with chemotherapy induced neutropena revealed a significant increase in the number of white blood cells and neutrophils following 10 days consumption of chamomile oral drop. Such a beneficial complementary therapy would naturally decreases the need for Granulocyte Colony Stimulating Factor (GCSF) and its related complications in these patients.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectChemistry
  • SubjectDentistry & Oral Health
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Babak Daneshfard”